ID   DCNL1_MOUSE             Reviewed;         259 AA.
AC   Q9QZ73; Q3TMX2; Q8CDZ7;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   07-APR-2021, entry version 148.
DE   RecName: Full=DCN1-like protein 1 {ECO:0000305};
DE            Short=DCNL1 {ECO:0000250|UniProtKB:Q96GG9};
DE   AltName: Full=DCUN1 domain-containing protein 1;
DE   AltName: Full=Defective in cullin neddylation protein 1-like protein 1;
DE   AltName: Full=Testis-specific protein 3;
GN   Name=Dcun1d1 {ECO:0000312|MGI:MGI:2150386}; Synonyms=Dcun1l1, Rp42, Tes3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=10831844; DOI=10.1016/s0378-1119(00)00158-x;
RA   Pourcel C., Jaubert J., Hadchouel M., Wu X., Schweizer J.;
RT   "A new family of genes and pseudogenes potentially expressing testis-
RT   specific and brain-specific leucine-zipper proteins in man and mouse.";
RL   Gene 249:105-113(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Telencephalon;
RX   PubMed=10777668; DOI=10.1006/geno.2000.6126;
RA   Mas C., Bourgeois F., Bulfone A., Levacher B., Mugnier C., Simonneau M.;
RT   "Cloning and expression analysis of a novel gene, RP42, mapping to an
RT   autism susceptibility locus on 6q16.";
RL   Genomics 65:70-74(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Colon, Head, and Stomach;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=20563250; DOI=10.1593/neo.10202;
RA   Broderick S.R., Golas B.J., Pham D., Towe C.W., Talbot S.G., Kaufman A.,
RA   Bains S., Huryn L.A., Yonekawa Y., Carlson D., Hambardzumyan D.,
RA   Ramanathan Y., Singh B.;
RT   "SCCRO promotes glioma formation and malignant progression in mice.";
RL   Neoplasia 12:476-484(2010).
CC   -!- FUNCTION: Part of an E3 ubiquitin ligase complex for neddylation.
CC       Promotes neddylation of cullin components of E3 cullin-RING ubiquitin
CC       ligase complexes (By similarity). Acts by binding to cullin-RBX1
CC       complexes in the cytoplasm and promoting their nuclear translocation,
CC       enhancing recruitment of E2-NEDD8 (UBE2M-NEDD8) thioester to the
CC       complex, and optimizing the orientation of proteins in the complex to
CC       allow efficient transfer of NEDD8 from the E2 to the cullin substrates.
CC       Involved in the release of inhibitory effets of CAND1 on cullin-RING
CC       ligase E3 complex assembly and activity (By similarity). Acts also as
CC       an oncogene facilitating malignant transformation and carcinogenic
CC       progression (PubMed:20563250). {ECO:0000250|UniProtKB:Q96GG9,
CC       ECO:0000269|PubMed:20563250}.
CC   -!- SUBUNIT: Part of an E3 complex for neddylation composed of cullins,
CC       RBX1, UBE2M and CAND1. Interacts (via the DCUN1 domain) with the
CC       unneddylated cullins: interacts with CUL1, CUL2, CUL3, CUL4A, CUL4B and
CC       CUL5; these interactions promote the cullin neddylation and the
CC       identity of the cullin dictates the affinity of the interaction. Binds
CC       neddylated CUL1. Interacts (via the C-terminus 50 AA) directly with
CC       RBX1. Interacts (via DCUN1 domain) with the N-terminally acetylated
CC       form of UBE2M and UBE2F. Interacts preferentially with UBE2M-NEDD8
CC       thioester (via N-terminus 1-26 AA) than with free UBE2M. UBE2M N-
CC       terminal acetylation increases the affinity of this interaction by
CC       about 2 orders of magnitude. Interacts with CAND1; this interaction is
CC       indirect and is bridged by cullins such as CUL1 and CUL3. May also
CC       interact with regulators or subunits of cullin-RING ligases such as
CC       RNF7, ELOB and DDB1; these interactions are bridged by cullins.
CC       Component of VCB complex that contains at least DCUN1D1, CUL2 and VHL;
CC       this complex triggers CUL2 neddylation and consequently cullin ring
CC       ligase (CRL) substrates polyubiquitylation. Interacts with VHL; this
CC       interaction triggers engagement of HIF1A in the VCB complex and is
CC       independent of CUL2. Interacts with CUL2 independently of VHL.
CC       Interacts with SOCS1 and SOCS2. Interacts with HIF1A; this interaction
CC       increases the interaction between VHL and DCUN1D1. Interacts (via UBA-
CC       like domain) with ARIH2; promotes DCUN1D1 ubiquitination.
CC       {ECO:0000250|UniProtKB:Q96GG9}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96GG9}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q96GG9}. Note=The ubiquitinated form is
CC       localized in the cytoplasm. {ECO:0000250|UniProtKB:Q96GG9}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Also expressed in
CC       brain, heart, liver, skeletal muscle and kidney. In brain,
CC       preferentially expressed in the telencephalon ventricular and
CC       subventricular zones, albeit at low levels. In adult testis, expressed
CC       in cells above seminiferous tubules, but only weakly in spermatogonia.
CC       {ECO:0000269|PubMed:10777668, ECO:0000269|PubMed:10831844}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the developing forebrain, midbrain
CC       and hindbrain at early stages of neuronal development.
CC       {ECO:0000269|PubMed:20563250}.
CC   -!- DOMAIN: The DCUN1 domain, also known as PONY domain, mediates the
CC       interaction with different cullins. The DCUN1 domain mediates the
CC       interaction with the N-terminally acetylated NEDD8-conjugating E2s
CC       enzyme leading to the NEDD8 transfer from N-terminally acetylated
CC       NEDD8-conjugating E2s enzyme to different cullin C-terminal domain-RBX
CC       complexes; the neddylation efficiency correlates with the DCUN1D1-
CC       cullin and DCUN1D1-E2 interaction affinities. The UBA-like domain
CC       mediates interaction with autoubiquitylated ARIH2 leading to ubiquitin
CC       ligation to DCUN1D1. {ECO:0000250|UniProtKB:Q96GG9}.
CC   -!- PTM: Mono- and poly-ubiquitinated by ARIH2 and ARIH1.
CC       Monoubiquitination by ARIH2 is mediated by an interaction between
CC       autoubiquitinated ARIH2 and the UBA-like domain. The monoubiquitinated
CC       form preferentially interacts with non-neddylated cullins and modulates
CC       cullin RING ligase (CRL) complex composition and activity.
CC       {ECO:0000250|UniProtKB:Q96GG9}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC26390.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF198092; AAF04863.1; -; mRNA.
DR   EMBL; AK008657; BAB25813.1; -; mRNA.
DR   EMBL; AK029314; BAC26390.1; ALT_INIT; mRNA.
DR   EMBL; AK155081; BAE33033.1; -; mRNA.
DR   EMBL; AK165651; BAE38318.1; -; mRNA.
DR   EMBL; BC020161; AAH20161.1; -; mRNA.
DR   EMBL; BC031666; AAH31666.1; -; mRNA.
DR   EMBL; BC037431; AAH37431.1; -; mRNA.
DR   CCDS; CCDS57207.1; -.
DR   RefSeq; NP_001192290.1; NM_001205361.1.
DR   SMR; Q9QZ73; -.
DR   BioGRID; 227901; 23.
DR   STRING; 10090.ENSMUSP00000113594; -.
DR   iPTMnet; Q9QZ73; -.
DR   PhosphoSitePlus; Q9QZ73; -.
DR   EPD; Q9QZ73; -.
DR   MaxQB; Q9QZ73; -.
DR   PaxDb; Q9QZ73; -.
DR   PRIDE; Q9QZ73; -.
DR   ProteomicsDB; 279603; -.
DR   DNASU; 114893; -.
DR   Ensembl; ENSMUST00000108182; ENSMUSP00000103817; ENSMUSG00000027708.
DR   GeneID; 114893; -.
DR   KEGG; mmu:114893; -.
DR   UCSC; uc008oyw.2; mouse.
DR   CTD; 54165; -.
DR   MGI; MGI:2150386; Dcun1d1.
DR   eggNOG; KOG3077; Eukaryota.
DR   GeneTree; ENSGT00940000154552; -.
DR   InParanoid; Q9QZ73; -.
DR   OrthoDB; 1418097at2759; -.
DR   PhylomeDB; Q9QZ73; -.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   BioGRID-ORCS; 114893; 4 hits in 53 CRISPR screens.
DR   ChiTaRS; Dcun1d1; mouse.
DR   PRO; PR:Q9QZ73; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q9QZ73; protein.
DR   Bgee; ENSMUSG00000027708; Expressed in testis and 285 other tissues.
DR   Genevisible; Q9QZ73; MM.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; ISO:MGI.
DR   GO; GO:0097602; F:cullin family protein binding; ISS:UniProtKB.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0032182; F:ubiquitin-like protein binding; IBA:GO_Central.
DR   GO; GO:2000436; P:positive regulation of protein neddylation; ISS:UniProtKB.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; IBA:GO_Central.
DR   GO; GO:0045116; P:protein neddylation; IBA:GO_Central.
DR   GO; GO:2000434; P:regulation of protein neddylation; ISS:UniProtKB.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; ISS:UniProtKB.
DR   Gene3D; 1.10.238.200; -; 1.
DR   InterPro; IPR014764; DCN-prot.
DR   InterPro; IPR042460; DCN1-like_PONY.
DR   InterPro; IPR005176; PONY_dom.
DR   InterPro; IPR009060; UBA-like_sf.
DR   PANTHER; PTHR12281; PTHR12281; 1.
DR   Pfam; PF03556; Cullin_binding; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   PROSITE; PS51229; DCUN1; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Cytoplasm; Nucleus; Proto-oncogene; Reference proteome;
KW   Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN           1..259
FT                   /note="DCN1-like protein 1"
FT                   /id="PRO_0000129499"
FT   DOMAIN          8..45
FT                   /note="UBA-like"
FT   DOMAIN          60..248
FT                   /note="DCUN1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00574"
FT   SITE            115
FT                   /note="Essential for interaction with UBE2M"
FT                   /evidence="ECO:0000250|UniProtKB:Q96GG9"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96GG9"
FT   CONFLICT        13
FT                   /note="R -> S (in Ref. 3; BAC26390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        115
FT                   /note="C -> F (in Ref. 3; BAC26390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="V -> L (in Ref. 3; BAC26390)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   259 AA;  30097 MW;  06E095D5F58EF20A CRC64;
     MNKLKSSQKD KVRQFMIFTQ SSEKTAVSCL SQNDWKLDVA TDNFFQNPEL YIRESVKGSL
     DRKKLEQLYT RYKDPQDENK IGIDGIQQFC DDLALDPASI SVLIIAWKFR AATQCEFSKQ
     EFMDGMTELG CDSIEKLKAQ IPKMEQELKE PGRFKDFYQF TFNFAKNPGQ KGLDLEMAIA
     YWNLVLNGRF KFLDLWNKFL LEHHKRSIPK DTWNLLLDFS SMIADDMSNY DEEGAWPVLI
     DDFVEFARPQ IAGTKSTTV
//
